Brandon S. Dunn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Brandon S. Dunn has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Anupam K. Chakravarty
Department of Chemical and Systems Biology, Stanford University, 269 Campus Drive, Stanford, CA 94305, USA
1 shared publication - Daniel F. Jarosz
Department of Chemical and Systems Biology, Stanford University School of Medicine, 269 Campus Drive, Stanford, CA 94305, USA; Department of Developmental Biology, Stanford University School of Medicine, 269 Campus Drive, Stanford, CA 94305, USA
1 shared publication - Daniel J. McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA
1 shared publication - David J. H. Shih
School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, China
1 shared publication - Gordon Brent Mills
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
1 shared publication Jin-Yu Lu
Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06510
1 shared publication
Latest Publications
- Open Access
- 19 July 2022
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 12 (9) , 2031-2043
Biomolecular Condensation: A New Phase in Cancer Research
Multicellularity was a watershed development in evolution. However, it also meant that individual cells could escape regulatory mechanisms that restrict proliferation at a severe cost to the organism: cancer. From the standpoint of cellular organization, evolutionary complexity scales to organize different molecules within the intracellular milieu. The recent realization that many biomolecules can “phase-separate” into membraneless organelles, reorganizing cellular biochemistry in space and time, has led to an explosion of research activity in this area. In this review, we explore mechanistic connections between phase separation and cancer-associated processes and emerging examples of how these become deranged in malignancy. Significance: One of the fundamental functions of phase separation is to rapidly and dynamically respond to environmental perturbations. Importantly, these changes often lead to alterations in cancer-relevant pathways and processes. This review covers recent advances in the field, including emerging principles and mechanisms of phase separation in cancer.
- 19 July 2022
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 12 (9) , 2031-2043
Open AccessBiomolecular Condensation: A New Phase in Cancer Research
Multicellularity was a watershed development in evolution. However, it also meant that individual cells could escape regulatory mechanisms that restrict proliferation at a severe cost to the organism: cancer. From the standpoint of cellular organization, evolutionary complexity scales to organize different molecules within the intracellular milieu. The recent realization that many biomolecules can “phase-separate” into membraneless organelles, reorganizing cellular biochemistry in space and time, has led to an explosion of research activity in this area. In this review, we explore mechanistic connections between phase separation and cancer-associated processes and emerging examples of how these become deranged in malignancy. Significance: One of the fundamental functions of phase separation is to rapidly and dynamically respond to environmental perturbations. Importantly, these changes often lead to alterations in cancer-relevant pathways and processes. This review covers recent advances in the field, including emerging principles and mechanisms of phase separation in cancer.
- 30 July 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (33) , 8358-8363
Mutations in the Drosophila tricellular junction protein M6 synergize with Ras V12 to induce apical cell delamination and invasion
Significance: Complications from metastasis are responsible for the majority of cancer-related deaths, yet we understand relatively little about how cells initiate metastasis and depart from their original tissues. To uncover the cellular and molecular mechanisms governing departure of a tumor cell from its tissue, we show here that, in a Drosophila cancer model, invasion can be initiated through apical delamination. Furthermore, this apical delamination occurs as a result of alterations in the junctions between three neighboring cells, termed “tricellular junctions.” This work provides evidence that apical delamination can initiate invasion in certain contexts and highlights the important role that tricellular junction integrity can play in this process.
- 30 July 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (33) , 8358-8363
Mutations in the Drosophila tricellular junction protein M6 synergize with Ras V12 to induce apical cell delamination and invasion
Significance: Complications from metastasis are responsible for the majority of cancer-related deaths, yet we understand relatively little about how cells initiate metastasis and depart from their original tissues. To uncover the cellular and molecular mechanisms governing departure of a tumor cell from its tissue, we show here that, in a Drosophila cancer model, invasion can be initiated through apical delamination. Furthermore, this apical delamination occurs as a result of alterations in the junctions between three neighboring cells, termed “tricellular junctions.” This work provides evidence that apical delamination can initiate invasion in certain contexts and highlights the important role that tricellular junction integrity can play in this process.
- Open Access
- 21 June 2017
- Published by Taylor & Francis in Fly
- Vol. 11 (4) , 271-276
The dark side of hippo signaling: A cancer promoter role
The Hippo signaling pathway regulates organ size and tissue homeostasis. Given this role it is unsurprising that dysregulation of this pathway has implications for cancer progression. A convincing body of literature shows that the Hippo pathway serves a tumor suppressive function with its inactivation leading to massive overgrowth. However, additional studies have also shown that activation of Hippo signaling can promote tumor progression. It remains unknown how a single pathway can produce such diametrically opposed effects. This lack of knowledge is in part due to our inability to make meaningful comparisons from studies which have taken place in a variety of cell types, tissues, and organisms. Recently however, we have published 2 studies using the Drosophila wing disk to study the Hippo pathway and have found that Hippo pathway activation can promote cell migration and invasion while Hippo pathway inactivation leads to overgrowth. Thus we propose here that Drosophila can provide a research platform with which to begin addressing how the Hippo pathway can both enhance and suppress tumor progression due to published pro- and anti-tumor functionalities of the Hippo pathway in the same tissue.
- 21 June 2017
- Published by Taylor & Francis in Fly
- Vol. 11 (4) , 271-276
Open AccessThe dark side of hippo signaling: A cancer promoter role
The Hippo signaling pathway regulates organ size and tissue homeostasis. Given this role it is unsurprising that dysregulation of this pathway has implications for cancer progression. A convincing body of literature shows that the Hippo pathway serves a tumor suppressive function with its inactivation leading to massive overgrowth. However, additional studies have also shown that activation of Hippo signaling can promote tumor progression. It remains unknown how a single pathway can produce such diametrically opposed effects. This lack of knowledge is in part due to our inability to make meaningful comparisons from studies which have taken place in a variety of cell types, tissues, and organisms. Recently however, we have published 2 studies using the Drosophila wing disk to study the Hippo pathway and have found that Hippo pathway activation can promote cell migration and invasion while Hippo pathway inactivation leads to overgrowth. Thus we propose here that Drosophila can provide a research platform with which to begin addressing how the Hippo pathway can both enhance and suppress tumor progression due to published pro- and anti-tumor functionalities of the Hippo pathway in the same tissue.